Newsroom

People in the organoid platform
News
Dr Katarina Barley, Member of the European Parliament, visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig on Tuesday, 30 April 2024. She was accompanied by Braunschweig's Mayor Dr Thorsten Kornblum and other party colleagues. During the visit, the management of the HZI, led by Prof. Josef Penninger and Christian Scherf, presented the current research program and the future strategy of the center. They also provided insights into the management of research data and the use of artificial intelligence.
30.04.2024
A participant of the Future Day 2024 in a laboratory
News
Today, around 70 students from years 5 to 9 visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig to get an idea of what it is like to work in a modern research facility. They got a taste of the world of science and its administration in ten scientific and two administrative departments.
25.04.2024
Bakteriophagen
News
The antimicrobial potential of CRISPR-Cas systems is promising, yet how to best design or implement CRISPR nucleases remains poorly understood. An international team led by the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg has now addressed this knowledge gap. The researchers conducted the first systematic interrogation of CRISPR antimicrobials using multidrug-resistant and hypervirulent bacteria as case studies, revealing wide variations in efficacy that could be predicted via high-throughput screening and machine learning. Their findings were published today in the journal Nucleic Acids Research.
25.04.2024
Vero6 cells (renal epithelial cells) infected with SARS-CoV-2
News
The so-called B cells are part of the immune system's memory. Their memories of previous infections or vaccinations provide the template for antibodies that have a protective effect the next time they come into contact with a pathogen. Researchers at TWINCORE, Centre for Clinical and Experimental Infection Research, have now been able to show that the combination of infection and subsequent vaccination in the case of the SARS-CoV-2 coronavirus even protects against future variants of the virus by the memory cells virtually predicting the future. The team describes how this works in the European Journal of Immunology. The TWINCORE is a joint institution of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and Hannover Medical School (MHH).
25.04.2024
Blood vessel organoid
Story
Scientists at the Helmholtz Centre for Infection Research (HZI) rely on working with laboratory animals to research infectious diseases in more detail and to understand the complex interactions between pathogens and their hosts. To this end, the HZI operates a central animal facility for breeding and keeping mice and hamsters.
24.04.2024
Group photo with Luka Cicin-Sain, Adhara Madhuri, Henrik Klimke
News
Leukemia is the most common cancer in children. Cancer treatment severely weakens the children's immune system and they can easily develop opportunistic infections. One of the most common causes of such complications is the cytomegalovirus (CMV) from the herpes virus family. The department “Viral Immunology” headed by Prof. Luka Cicin-Sain at the Helmholtz Centre for Infection Research (HZI) in Braunschweig is now investigating immunotherapy options against CMV. The project is enabled by a donation from the Günter Hansmeier Krebsstiftung in Braunschweig, which is funding the position of a doctoral researcher for three years.
15.04.2024

HZI in the media

... Vakzinologie und angewandte Mikrobiologie am Helmholtz-Zentrum für Infektionsforschung. Die M2-Membranproteinhemmer verhindern ...

02.11.2025
|
Augsburger Allgemeine

... etwas dran ist“, erklärt Biologe Marc Stadler vom Helmholtz-Zentrum für Infektionsforschung gegenüber der Barmer-Krankenkasse. „Es ...

30.10.2025
|
bild der wissenschaft

could be reintroduced at any time. Epidemiologists at the Helmholtz Center for Infection Research (HZI) have now shown that many people do

23.10.2025
|
MSN.com

... eingeschleppt werden könnte. Epidemiolog:innen des Helmholtz-Zentrums für Infektionsforschung (HZI) haben nun gezeigt, dass ...

23.10.2025
|
innovations report

this development, a research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in collaboration with the Swiss

22.10.2025
|
Phys.org

Malaria-Medikamentes ermöglichen könnte. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung in Zusammenarbeit mit ...

22.10.2025
|
Verband Deutscher Biologen e.V.

(Bild: DOI: 10.1021/jacs.5c08354 / Hips / CC BY 4.0) Wissenschaftler am Hips entwickelten eine Plattform zur Produktion von Furanoliden, die effektiv gegen Bakterien und Krebszellen wirken können und vielversprechende Wirkstoffe darstellen.

21.10.2025
|
PROCESS

at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in partnership with the Helmholtz Centre for Infection Research (HZI

20.10.2025
|
Bioengineer.org

their biological activity. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

20.10.2025
|
Phys.org

... die Abteilung „Experimentelle Immunologie“ am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig, lehrt als Professor an ...

17.10.2025
|
Deutsches Ärzteblatt

Einrichtungen als nationale assoziierte Partner: das Helmholtz-Zentrum für Infektionsforschung Braunschweig, die Universität Bayreuth, das

17.10.2025
|
AlphaGalileo

... diesem Ergebnis kommt ein Forschungsteam des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit mit der ...

14.10.2025
|
Deutsches Ärzteblatt

Register now for the HZI-Newsletter